Amphastar Pharmaceuticals, Inc. — Director's Dealing 2020

Jun 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2020-06-08

Reporting Person: ZASLOFF MICHAEL A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-08	Common Stock	A	5851	—	Acquired	41187	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-08	Stock Option (right to buy)	$20.08	A	16004	Acquired	2028-06-08	Common Stock (16004)	Direct

Footnotes

F1: The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 8, 2021.

F2: All of the shares subject to the option vest on June 8, 2021.